Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7776)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2014 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Baba Y, Watanabe M, Yoshida N, Baba H. Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol 2014; 6(5): 121-128 [PMID: 24834142 DOI: 10.4251/wjgo.v6.i5.121] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i5/121.htm |
| Number | Citing Articles |
| 1 |
Wenyan Lv, Jingyu Wang, Shubao Zhang. Effects of cisatracurium on epithelial‑to‑mesenchymal transition in esophageal squamous cell carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10859
|
| 2 |
Noori Akhtar-Danesh, Saad Shakeel, Hsien Seow, Gileh-Gol Akhtar-Danseh, Christian Finley. Trends in survival based on treatment modality for esophageal cancer: a population-based study. European Journal of Gastroenterology & Hepatology 2019; 31(10): 1192 doi: 10.1097/MEG.0000000000001498
|
| 3 |
Jun Xie, Lei Zhang, Zhen Liu, Chun-lei Lu, Guang-hui Xu, Man Guo, Xiao Lian, Jin-Qiang Liu, Hong-Wei Zhang, Shi-ying Zheng. Advantages of McKeown minimally invasive oesophagectomy for the treatment of oesophageal cancer: propensity score matching analysis of 169 cases. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02527-z
|
| 4 |
Munmee Dutta, Hidewaki Nakagawa, Hiroaki Kato, Kazuhiro Maejima, Shota Sasagawa, Kaoru Nakano, Aya Sasaki-Oku, Akihiro Fujimoto, Raúl Nicolás Mateos, Ashwini Patil, Hiroko Tanaka, Satoru Miyano, Takushi Yasuda, Kenta Nakai, Masashi Fujita. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma. PeerJ 2020; 8: e9294 doi: 10.7717/peerj.9294
|
| 5 |
James Tankel, Lorenzo Ferri. New Approaches to Neoadjuvant Treatment for Locally Advanced Esophageal Cancer. Foregut: The Journal of the American Foregut Society 2022; 2(2): 143 doi: 10.1177/26345161221108331
|
| 6 |
Yoshifumi Baba, Hideo Baba, Sachiko Yamamoto, Hideaki Shimada, Tomotaka Shibata, Tatsuya Miyazaki, Takaki Yoshikawa, Yasuaki Nakajima, Yasushi Tsuji, Mototsugu Shimokawa, Yuko Kitagawa, Keisuke Aiba. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan. Diseases of the Esophagus 2016; : n/a doi: 10.1111/dote.12482
|
| 7 |
Han Tang, Lijie Tan, Yaxing Shen, Hao Wang, Miao Lin, Mingxiang Feng, Songtao Xu, Weigang Guo, Cheng Qian, Tianshu Liu, Zhaochong Zeng, Yingyong Hou, Zhentao Yu, Hongjing Jiang, Zhigang Li, Chun Chen, Changhong Lian, Ming Du, Hecheng Li, Deyao Xie, Jun Yin, Naiqing Zhao, Qun Wang. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596). BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3446-7
|
| 8 |
Xia Chen, Bin Lu, Qian Ma, Cheng‑Dong Ji, Jian‑Zhong Li. EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal‑epithelial transition process. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4639
|
| 9 |
U. B. Urmonov, A. Yu. Dobrodeev, S. G. Afanasyev, A. V. Avgustinovich, M. Yu. Volkov, A. S. Tarasova, D. N. Kostromitsky. Combined modality treatment of stage II-III esophageal cancer: a single center experience. Experimental and Clinical Gastroenterology 2021; (7): 48 doi: 10.31146/1682-8658-ecg-191-7-48-55
|
| 10 |
D. W. Kjaer, M. Nassar, L. S. Jensen, L. B. Svendsen, F. V. Mortensen. A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival. Diseases of the Esophagus 2016; : n/a doi: 10.1111/dote.12474
|
| 11 |
U. B. Urmonov, A. Yu. Dobrodeev, S. G. Afanasyev, A. V. Avgustinovich, O. V. Cheremisina. MODERN ASPECTS OF TREATMENT OF ESOPHAGEAL CANCER. Siberian journal of oncology 2019; 18(4): 78 doi: 10.21294/1814-4861-2019-18-4-78-84
|
| 12 |
Jian He, Zhao-Chong Zeng, Shi-Ming Shi, Ping Yang. Clinical features, outcomes and treatment-related pneumonitis in elderly patients with esophageal carcinoma. World Journal of Gastroenterology 2014; 20(36): 13185-13190 doi: 10.3748/wjg.v20.i36.13185
|
| 13 |
Zhonglu Yang, Zhiyi Wu, Tao Liu, Lei Han, Chunhui Wang, Bo Yang, Fei Zheng. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Medical Oncology 2014; 31(12) doi: 10.1007/s12032-014-0337-5
|
| 14 |
ZHENHUA WANG, NING ZHANG, RUIFENG SONG, RUITAI FAN, LIUQIN YANG, LIPING WU. Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation. Oncology Letters 2015; 10(1): 143 doi: 10.3892/ol.2015.3248
|
| 15 |
Francesco Cellini, Stefania Manfrida, Calogero Casà, Angela Romano, Alessandra Arcelli, Alice Zamagni, Viola De Luca, Giuseppe Ferdinando Colloca, Andrea D’Aviero, Lorenzo Fuccio, Valentina Lancellotta, Luca Tagliaferri, Luca Boldrini, Gian Carlo Mattiucci, Maria Antonietta Gambacorta, Alessio Giuseppe Morganti, Vincenzo Valentini. Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation. Cancers 2022; 14(2): 431 doi: 10.3390/cancers14020431
|
| 16 |
Hiroko SEINO, Yunyan WU, Satoko MOROHASHI, Takeshi KAWAMOTO, Katsumi FUJIMOTO, Yukio KATO, Yoshihiro TAKAI, Hiroshi KIJIMA. <b>Basic helix-loop-helix transcription factor DEC1 regulates the cisplatin-induced apoptotic pathway of human esophageal cancer </b><b>cells </b>. Biomedical Research 2015; 36(2): 89 doi: 10.2220/biomedres.36.89
|
| 17 |
Shao-Zhi Xing, Ying Zhang. Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Supportive Care in Cancer 2015; 23(3): 753 doi: 10.1007/s00520-014-2419-5
|
| 18 |
Mai I. Shahin, Joyeeta Roy, Maha Hanafi, Dongyao Wang, Urarika Luesakul, Yifeng Chai, Nongnuj Muangsin, Deena S. Lasheen, Dalal A. Abou El Ella, Khaled A. Abouzid, Nouri Neamati. Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinoma. European Journal of Medicinal Chemistry 2018; 155: 516 doi: 10.1016/j.ejmech.2018.05.042
|
| 19 |
Pengjun Zhou, Rong Zhang, Ying Wang, Dandan Xu, Li Zhang, Jinhong Qin, Guifeng Su, Yue Feng, Hongce Chen, Siyuan You, Wen Rui, Huizhong Liu, Suhong Chen, Hongyuan Chen, Yifei Wang. Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. Oncotarget 2017; 8(67): 111144 doi: 10.18632/oncotarget.22676
|
| 20 |
Naoki Hijiya, Tomotaka Shibata, Tsutomu Daa, Ryoji Hamanaka, Tomohisa Uchida, Keiko Matsuura, Yoshiyuki Tsukamoto, Chisato Nakada, Hidekatsu Iha, Masafumi Inomata, Masatsugu Moriyama. Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis. Pathology International 2017; 67(2): 83 doi: 10.1111/pin.12495
|
| 21 |
Shegan Gao, Yiwen Liu, Xiaoxian Duan, Ke Liu, Muddasir Mohammed, Zhen Gu, Junling Ren, Lan Yakoumatos, Xiang Yuan, Lanhai Lu, Shuang Liang, Jiong Li, David A. Scott, Richard J. Lamont, Fuyou Zhou, Huizhi Wang. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. British Journal of Cancer 2021; 125(3): 433 doi: 10.1038/s41416-021-01419-5
|
| 22 |
Naoto Fujiwara, Jun Inoue, Tatsuyuki Kawano, Kousuke Tanimoto, Ken-ichi Kozaki, Johji Inazawa.
miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity. Cancer Research 2015; 75(18): 3890 doi: 10.1158/0008-5472.CAN-15-0257
|
| 23 |
Nuo Li, Yang Yu, Baoming Wang. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway. American Journal of Physiology-Cell Physiology 2020; 319(1): C93 doi: 10.1152/ajpcell.00133.2019
|
| 24 |
Guiming Chen, Jin Peng, Weiguo Zhu, Guangzhou Tao, Yaqi Song, Xilei Zhou, Wanwei Wang. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0263-6
|
| 25 |
Yoshifumi Baba, Naoya Yoshida, Hironobu Shigaki, Masaaki Iwatsuki, Yuji Miyamoto, Yasuo Sakamoto, Masayuki Watanabe, Hideo Baba. Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma. Annals of Surgery 2016; 264(2): 305 doi: 10.1097/SLA.0000000000001510
|
| 26 |
K. Kosumi, Y. Baba, K. Yamashita, T. Ishimoto, K. Nakamura, M. Ohuchi, Y. Kiyozumi, D. Izumi, R. Tokunaga, K. Harada, H. Shigaki, J. Kurashige, M. Iwatsuki, Y. Sakamoto, N. Yoshida, M. Watanabe, H. Baba. Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment. Diseases of the Esophagus 2017; 30(12): 1 doi: 10.1093/dote/dox092
|
| 27 |
Shaohua Ma, Tiansheng Yan, Dandan Liu, Keyi Wang, Jingdi Wang, Jintao Song, Tong Wang, Wei He, Jie Bai, Liang Jin, Xiaoxin Chen. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma. Thoracic Cancer 2018; 9(2): 310 doi: 10.1111/1759-7714.12590
|
| 28 |
Umidzhon Butabekovich Urmonov, Aleksey Yurievich Dobrodeev, Sergey Gennadievich Afanasyev, Aleksandra Vladimirovna Avgustinovich, Evgeniy Olegovich Rodionov . MULTIMODAL APPROACH TO THE TREATMENT OF ESOPHAGEAL CANCER. AVICENNA BULLETIN 2019; 21(2): 263 doi: 10.25005/2074-0581-2019-21-2-263-268
|
| 29 |
Anxi Hu, Abdullah A. Alarfaj, Abdurahman Hajinur Hirad, Vishnu Priya Veeraraghavan, Krishna Mohan Surapaneni, Samer Hasan Hussein-Al-Ali, Nandakumar Natarajan, Poorni Kaliyappan Elayappan. Chitosan-sodium alginate-polyethylene glycol-crocin nanocomposite treatment inhibits esophageal cancer KYSE-150 cell growth via inducing apoptotic cell death. Arabian Journal of Chemistry 2022; 15(6): 103844 doi: 10.1016/j.arabjc.2022.103844
|
| 30 |
Wentao Hao, Kun Gao, Keting Li, Yin Li, Zongfei Wang, Haibo Sun, Wenqun Xing, Yan Zheng. The Feasibility of Early Oral Feeding After Neoadjuvant Chemotherapy Combined With “Non-Tube No Fasting”-Enhanced Recovery. Annals of Surgical Oncology 2023; 30(3): 1564 doi: 10.1245/s10434-022-12620-y
|
| 31 |
HONGWU TAN, YUNFENG ZHU, JILING ZHANG, LIJUN PENG, TAO JI. miR141 expression is downregulated and negatively correlated with STAT5 expression in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine 2016; 11(5): 1803 doi: 10.3892/etm.2016.3098
|
| 32 |
Ming Li, Dongfeng Qiao, Juan Pu, Wanwei Wang, Weiguo Zhu, Haiyan Liu. Elevated Nectin-2 expression is involved in esophageal squamous cell carcinoma by promoting cell migration and invasion. Oncology Letters 2018; doi: 10.3892/ol.2018.7953
|
| 33 |
Josephine Mun Yee Ko, Hoi Yan Ng, Ka On Lam, Keith Wan Hang Chiu, Dora Lai Wan Kwong, Anthony Wing Ip Lo, Jean Chrysei Wong, Roger Chia Wei Lin, Henry Chun Hung Fong, Jason Ying Ki Li, Wei Dai, Simon Law, Maria Li Lung. Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma. Cancers 2020; 12(6): 1352 doi: 10.3390/cancers12061352
|
| 34 |
Dongfeng Qiao, Ming Li, Juan Pu, Wanwei Wang, Weiguo Zhu, Haiyan Liu. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma. Pathology & Oncology Research 2016; 22(3): 541 doi: 10.1007/s12253-015-0036-3
|
| 35 |
Yusen Zhu, Min Liu, Xiaojing Yun, Dongmei Wang, Yuhuan Bai, Guizhi Zhang, Bei Ji, Changchun Jing. Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer. Pathology & Oncology Research 2017; 23(3): 657 doi: 10.1007/s12253-016-0164-4
|
| 36 |
Xiaozhong Liao, Ying Gao, Jiahui Liu, Lanting Tao, Dongmei Wang, Dan Xie, Suilin Mo. RETRACTED: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01756
|
| 37 |
Miao-Fen Chen, Ping-Tsung Chen, Ming- Shian Lu, Chuan-Pin Lee, Wen-Cheng Chen. Survival benefit of surgery to patients with esophageal squamous cell carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/srep46139
|
| 38 |
Fei He, Haojie Wang, Yong Li, Weichao Liu, Xiang Gao, Dong Chen, Qianqian Wang, Gongning Shi. SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2019; 109: 671 doi: 10.1016/j.biopha.2018.10.042
|
| 39 |
Shihao Gao, Zhangzhan Wang, Xiaozhe Liu, Bing Xu, Fengjin Liu. The calcimedin annexin A3 displays tumor-promoting effect in esophageal squamous cell carcinoma by activating NF-κB signaling. Mammalian Genome 2021; 32(5): 381 doi: 10.1007/s00335-021-09883-3
|
| 40 |
Yan Zheng, Yin Li, Xianben Liu, Haibo Sun, Zongfei Wang, Ruixiang Zhang. Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Medicine 2015; 94(27): e1102 doi: 10.1097/MD.0000000000001102
|
| 41 |
Yusuke Taniyama, Kentaro Murakami, Naoya Yoshida, Kozue Takahashi, Hisahiro Matsubara, Hideo Baba, Takashi Kamei. Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08747-y
|
| 42 |
Jin Zhang, Danjie Zhang, Liangzhang Sun. Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(2): 249 doi: 10.3727/096504016X693164
|
| 43 |
Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri S. Mackie. A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma. Thoracic Cancer 2022; 13(9): 1240 doi: 10.1111/1759-7714.14334
|
| 44 |
F.C. Mota, I. Cecconello, F.R. Takeda, F. Tustumi, R.A.A. Sallum, W.M. Bernardo. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. International Journal of Surgery 2018; 54: 176 doi: 10.1016/j.ijsu.2018.04.053
|